Sangamo Biosciences is putting a different spin on gene therapy.
View Full Profile.
Learn about our Editorial Policies.
Infographic: Messing with HIV
View full size JPG | PDFLUCY READING-IKKANDA
Sangamo Biosciences is putting a different spin on gene therapy. Rather than replace or supplement a mutated gene with an accurate copy, Sangamo researchers are introducing a mutant copy of the gene for the HIV co-receptor CCR5 into the T cells of HIV patients. This prevents the expression of CCR5 on the cell’s surface, and thus inhibits HIV from infecting cells.
Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.
View this Issue
Learn how improving sampling, standardization, and calibration streamlines quality control processes.
In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.
Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating technology options for their laboratories.
- Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network - Hypothermic preservation technology eliminates costs and inefficiencies of cold-chain logistics to enhance biomedical research and cell therapy development
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Singleron Biotechnologies and Hamilton Bonaduz AG today announced the official launch of Tensor under their strategic partnership.
Zymo Research is proud to introduce the RNome Disruptive Research Grant, that is designed to empower scientists mapping the RNome and advance our overallunderstanding of RNA.
